Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2006
03/29/2006EP1346039B1 Human cervical cancer 2 protooncogene and protein encoded therein
03/29/2006EP1320552B1 Method for producing human anti-thymocyte immunoglobulins
03/29/2006EP1290197B1 Leader peptides for enhancing secretion of recombinant protein from a host cell
03/29/2006EP1050542B1 Novel potassium channel protein
03/29/2006EP1005363B1 Recombinant dimeric envelope vaccine against flaviviral infection
03/29/2006EP0990031B1 Tumor necrosis factor receptor 5
03/29/2006EP0961829B1 Fusion proteins for intracellular and intercellular transport and their uses
03/29/2006EP0944722B1 Pituitary-tumor-transforming-genes, and related products
03/29/2006EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin
03/29/2006EP0807170B1 Transgenic pigs expressing human coagulation factor viii
03/29/2006EP0759465B1 Gene imparting flocculability to yeast and gene product
03/29/2006EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases
03/29/2006CN1753991A Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent
03/29/2006CN1753909A Peptides and pharmaceutical compositions comprising said peptides and medical composition for treating cancer
03/29/2006CN1752211A Recombination targent fused protein for treating acquired immunodeficiency syndrome
03/29/2006CN1247794C Production process of human horny cell growth factor-2
03/29/2006CN1247793C Production process of vascular endothelial cell inhibine
03/29/2006CN1247792C Method for preparing bioactive micro peptide of plant protein
03/29/2006CN1247791C Process for obtaining amino-acid ingredient by zymohydrolysis of roe skin
03/29/2006CN1247785C Cytomegalovirus intron A fragments
03/29/2006CN1247777C Polypeptides having aminopepyidase activity and nucleic acids encoding same
03/29/2006CN1247616C New monomeric insulin, its medicinal composition and prepn process
03/29/2006CN1247615C Purification of human myocardium troponin I and preparation method of its monoclonal anti-body
03/29/2006CN1247613C Novel omega-conotoxin peptides
03/29/2006CN1247575C Sulfamino ether substituted imidazoquinolines
03/29/2006CN1247254C Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
03/28/2006US7019197 fusion protein containing toxin domain and binding domain; corn/rice plants
03/28/2006US7019193 Treatments using transgenic goat produced antithrombin III
03/28/2006US7019125 Chlamydia antigens and corresponding DNA fragments and uses thereof
03/28/2006US7019123 Human bikunin
03/28/2006US7019116 PRO 1387 polypeptides
03/28/2006US7019114 Recombinant, biologically active human zona pellucida protein 3 (HZP3) to test male fertility
03/28/2006US7018846 Display of receptors and analysis of binding interactions and drug libraries
03/28/2006US7018839 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
03/28/2006US7018824 water soluble transferase enzyme polypeptides, coded by exogenous DNA; glycosylation
03/28/2006US7018817 Process for the preparation of compounds with enhanced optical purity
03/28/2006US7018814 Process of purifying vancomycin hydrochloride
03/28/2006US7018813 Method for the production of bacterial toxins
03/28/2006US7018811 Nucleic acids encoding PRO189 polypeptides
03/28/2006US7018810 Chordin-like molecules and uses thereof
03/28/2006US7018809 gene expression of heavy and light chain Fv fragments in prokaryotic host cell cultures, then recovering the fab fragment secreted to the periplasm under conditions that maintain cysteine residue as free thiols, which can then react with free thiol of other fragments, labels or drugs; homogeneity; purity
03/28/2006US7018801 Screening assay for identification of peptides having target binding affinity; protein purification, post-translational modification; prokaryotic operator region linked to coding region for indicator polypeptides
03/28/2006US7018639 polypeptide and optionally carrier and/or adjuvants having haemolysin activity used for inoculation against gramnegative bacteria; immunology
03/28/2006US7018634 Surface proteins of Leptospira
03/28/2006US7018632 Isolation of tumor cells; incubation
03/28/2006US7018630 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan
03/28/2006CA2131874C Diagnostic reagents for the detection of antibodies to ebv
03/28/2006CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype
03/23/2006WO2006031992A2 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes
03/23/2006WO2006031928A2 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof
03/23/2006WO2006031840A2 Increasing the stability of recombinant adult human apohemoglobin
03/23/2006WO2006031644A2 Immobilized probes and methods of detecting conformationally altered prion proteins
03/23/2006WO2006031327A2 Cloning and expression of recombinant adhesive protein mefp-2 of the blue mussel, mytilus edulis
03/23/2006WO2006031253A2 Plasmon nanoparticles and pixels, displays and inks using them
03/23/2006WO2006030883A1 Method of producing monoclonal antibody
03/23/2006WO2006030840A1 Process for synthesis of mucin-type peptides and muc1-related glycopeptides
03/23/2006WO2006029538A1 Sialyltransferases comprising conserved sequence motifs
03/23/2006WO2005019251A3 Novel fungal proteins and nucleic acids encoding same
03/23/2006WO2004104180A3 Genes encoding carotenoid biosynthetic enzymes
03/23/2006WO2003083085A3 Transporters and ion channels
03/23/2006US20060064765 Obesity gene
03/23/2006US20060064764 Increasing gamete production with a gene switch
03/23/2006US20060063924 Leukocyte regulatory factors 1 and 2
03/23/2006US20060063923 4-1BB peptides and methods for use
03/23/2006US20060063922 Epidermal differentiation factor
03/23/2006US20060063716 Intermedin and its uses
03/23/2006US20060063715 Multivalent antigen-binding proteins
03/23/2006US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
03/23/2006US20060063249 Human cathepsin
03/23/2006US20060063244 Comprises ribonuclease barnase marker gene; libraries; drug resistance
03/23/2006US20060063243 Cloning and expression of microbial phytase
03/23/2006US20060063236 Interleukin-4 (IL-4) mutein receptor antagonist operatively linked to an interleukin-9 (IL-9) mutein receptor antagonist; can specifically disrupt the formation of an IL-4 receptor, an IL-9 receptor, an interleukin-13 (IL-13) receptor; useful in treatment of asthma and other pulmonary disorders
03/23/2006US20060063235 DNA encoding the human serine protease C-E
03/23/2006US20060063234 Efficient production of IgM in recombinant mammalian cells
03/23/2006US20060063233 Cytokine protein family
03/23/2006US20060063232 Host-vector system for antibiotic-free CoIE1 plasmid propagation
03/23/2006US20060063231 Compositions and methods for protein production
03/23/2006US20060063230 Sulfatases and methods of use thereof
03/23/2006US20060063229 mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof
03/23/2006US20060063228 Antibodies against human interleukin-13 and uses therefor
03/23/2006US20060063227 Secreted proteins and polynucleotides encoding them
03/23/2006US20060063215 Human GAK-related gene variants associated with lung cancer
03/23/2006US20060063203 Vascular endothelial cell growth factor variants and uses thereof
03/23/2006US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/23/2006US20060063179 MIFL- a new partner gene of MLL and methods of use thereof
03/23/2006US20060063172 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
03/23/2006US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications
03/23/2006US20060063156 Outcome prediction and risk classification in childhood leukemia
03/23/2006US20060063152 Novel gene and protein encoded by the gene
03/23/2006US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
03/23/2006US20060062799 Sperm specific lysozyme-like proteins
03/23/2006US20060062795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
03/23/2006US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
03/23/2006US20060062788 Method for determining MIF content
03/23/2006US20060062786 Antibodies that immunospecifically bind to TRAIL receptors
03/23/2006US20060062782 Anti-IgE vaccines
03/23/2006US20060062781 Specific ab1'-antibodies against tumour-associated antigen ca 125
03/23/2006US20060062780 Myelin oligodendrocyte glycoprotein; 1st domain: deimmunized, autoreactive antigen specifically recognized by Ig receptors of autoreactive B-cells; 2nd domain: effector molecule capable of interacting with or activating NK-cells, T-cells, macrophages, monocytes or granulocytes; autoimmune diseases
03/23/2006US20060062779 Methods and compositions relating to mannuronic acid specific binding peptides
03/23/2006US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9)